Search results for "BES"

showing 10 items of 3692 documents

Clinical and haemodynamic effects of ketanserin in lean and obese hypertensive patients.

1990

Systemic and central haemodynamics were evaluated in 10 lean and 10 obese hypertensive patients (World Health Organization stage I – II) after treatment for 8 weeks with a serotoninergic antagonist, such as ketanserin. Blood pressure and heart rate were recorded and first-pass radionuclide angiocardiography was performed to determine cardiac output, cardiac index and ejection fraction of the left ventricle; total peripheral resistance was also calculated. In both obese and lean patients, ketanserin significantly reduced diastolic ( P < 0.05) and mean ( P < 0.005) blood pressure but no significant changes in systolic blood pressure, cardiac output, cardiac index and ejection fraction …

AdultMalemedicine.medical_specialtyCardiac outputKetanserinDiastoleCardiac indexHemodynamicsBlood PressureBiochemistryInternal medicineHeart ratemedicineHumansObesityCardiac OutputEjection fractionbusiness.industryBiochemistry (medical)HemodynamicsCell BiologyGeneral MedicineMiddle AgedLipidsEndocrinologyBlood pressureHypertensionCardiologyFemaleVascular ResistanceKetanserinbusinessmedicine.drugThe Journal of international medical research
researchProduct

Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricul…

1994

This study was designed to evaluate total (t) and surface (s) β-adrenergic receptor (BAR) density and their relationship with central haemodynamics and left ventricular function in young subjects with central or peripheral obesity. A total of 31 obese subjects (BMI ≥30.5 kg. m−2 for males and >27.3 kg. m−2 for females) aged less than 40 years and without other risk factors for cardiovascular diseases (smoking, hypertension, diabetes and lipid abnormalities) were studied. Nine had peripheral obesity and 22 central obesity according to WHR values; there were 20 lean controls (BMI <25 kg. m−2 for males and <24.7 kg. m−2 for females). Casual (c) and 24 h ambulatory mean blood pressures (MBP-24 …

AdultMalemedicine.medical_specialtyCardiac outputSettore MED/09 - Medicina InternaMegalencephalic leukoencephalopathy with subcortical cystsEpinephrineDiastoleHemodynamicsBlood volumeVentricular Function LeftBody Mass IndexNorepinephrineRisk FactorsInternal medicineDiabetes mellitusReceptors Adrenergic betamedicineHumansInsulinLymphocytesObesitySystoleRadionuclide ImagingEjection fractionbusiness.industryHemodynamicsHeartmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyCardiovascular DiseasesEchocardiographyBody ConstitutionRegression AnalysisPeripheral obesity Central Obesity Lymphocyte beta adrenergic receptors left ventricular functionFemaleCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subj…

1994

This study was designed to evaluate the role of fasting serum insulin and plasma renin activity in obesity-induced hypertension. In view of this, plasma catecholamines, fasting serum insulin (IRI), urinary sodium excretion (NaU), plasma renin activity (PRA), and plasma aldosterone (PA) levels were assessed in young (age less than 40 years) normotensive (n = 27) and hypertensive (n = 14) subjects with central obesity and in lean normotensives (n = 20). Central obesity was evaluated by waist-to-hip ratio (WHR) according to the indication of the Italian Consensus Conference of Obesity. PRA, PA, IRI, and plasma norepinephrine levels were significantly (P < .05) higher in both obese groups than …

AdultMalemedicine.medical_specialtyCentral obesityHypertension Insulin Renin-angiotensin-aldosterone systemSettore MED/09 - Medicina Internamedicine.medical_treatmentBlood Pressureurologic and male genital diseasesPlasma renin activitySettore MED/13 - Endocrinologiachemistry.chemical_compoundDiastoleReference ValuesInternal medicineRenin–angiotensin systemBlood plasmaReninInternal MedicinemedicineHumansInsulinObesityAldosteronebusiness.industryInsulinFastingmedicine.diseaseObesitySettore MED/11 - Malattie Dell'Apparato Cardiovascolarefemale genital diseases and pregnancy complicationsEndocrinologyBlood pressurechemistryHypertensionFemalebusinessBody mass index
researchProduct

Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients

2009

Although many studies have shown that the metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) both are associated with chronic inflammatory state and are risk factors for coronary artery disease (CAD), it is still unclear which condition is a more important contributor to the increased production of inflammatory chemokines. The purpose of this study was to assess monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) levels and their association with insulin resistance and adiponectin concentrations in CAD patients, who were categorized as having T2DM, MS, or neither.CAD male patients were categorized into three groups: 24 non-obese patients with T2DM (D), 24 obese pati…

AdultMalemedicine.medical_specialtyChemokineDecreased adiponectinCoronary Artery DiseaseCoronary artery diseaseInsulin resistanceRisk FactorsInternal medicineInternal MedicinemedicineHumansObesityChemokine CCL2AgedMetabolic SyndromeAdiponectinbiologybusiness.industryMonocyteInterleukin-8nutritional and metabolic diseasesType 2 Diabetes MellitusMiddle Agedmedicine.diseasemedicine.anatomical_structureEndocrinologyDiabetes Mellitus Type 2biology.proteinAdiponectinInsulin ResistanceMetabolic syndromebusinessBiomarkersEuropean Journal of Internal Medicine
researchProduct

Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity

2021

Abstract Background and aims Obesity is a key contributing factor to incidental type 2 diabetes and cardiovascular disease. CXCR3 receptor and its ligands CXCL 10 and 11 are associated with atherosclerosis and cardiovascular disease. The aim of our study was to analyse the role of the CXCR3 ligands on insulin resistance (IR) and endothelial dysfunction in human obesity. Methods and results We have studied 45 obese patients (mean age 44 ± 6 years, body mass index 45 ± 9 kg/m2) who were selected for Roux-Y-gastric bypass surgery and 21 non obese control subjects with similar age and gender distribution. We measured by ELISA the circulating levels of the CXCR3 ligands interferon-γ inducible pr…

AdultMalemedicine.medical_specialtyChemokineReceptors CXCR3Type 2 diabetesCXCR3BiochemistryInsulin resistanceInternal medicineCell AdhesionLeukocytesmedicineHumansCXCL10CXCL11ObesityEndothelial dysfunctionCells CulturedbiologyTumor Necrosis Factor-alphabusiness.industryEndothelial CellsCell BiologyMiddle Agedmedicine.diseaseChemokine CXCL11Up-RegulationChemokine CXCL10EndocrinologyCase-Control Studiesbiology.proteinFemaleInsulin ResistanceCardiology and Cardiovascular MedicinebusinessBody mass indexSignal TransductionMicrovascular Research
researchProduct

Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals

2018

Background &amp; Aims: Transient elastography (TE) is a noninvasive technique used to measure liver stiffness to estimate the severity of fibrosis. The range of liver stiffness measurements (LSMs) in healthy individuals is unclear. We performed a systematic review to determine the range of LSMs, examined by TE, in healthy individuals and individuals who are susceptible to fibrosis. Methods: We collected data from 16,082 individuals, in 26 cohorts, identified from systematic searches of Embase, Ovid MEDLINE, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews for studies of liver stiffness measurements. Studies analyzed included apparently healthy adul…

AdultMalemedicine.medical_specialtyCirrhosisAdolescent03 medical and health sciencesYoung AdultBMI0302 clinical medicineInternal medicineDiabetes mellitusNonalcoholic fatty liver diseasemedicineHumansObesityAgedAged 80 and overCirrhosiAnthropometryHepatologybusiness.industryGastroenterologyBMI; Cirrhosis; Fibroscan; Obesity; Hepatology; GastroenterologyMiddle Agedmedicine.diseaseElasticityHealthy VolunteersFibroscanLiver030220 oncology & carcinogenesisCohortElasticity Imaging Techniques030211 gastroenterology & hepatologyFemaleMetabolic syndromeTransient elastographybusinessBody mass indexDyslipidemiaClinical Gastroenterology and Hepatology
researchProduct

The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods

2020

Background. Bariatric surgery patients have a higher prevalence of nonalcoholic fatty liver (NAFL) than the general population; however, its assessment and the accurate staging of fibrosis are often complicated because noninvasive tests are not very accurate in patients with morbid obesity, and liver biopsy cannot be performed as a routine exam. The aim of this study was to evaluate (A) the histological prevalence of NAFL, nonalcoholic steatohepatitis (NASH), and fibrosis in patients undergoing bariatric surgery; (B) the reliability of ultrasound (US) in diagnosing NAFL; and (C) the reliability of various fibrosis scoring systems for defining fibrosis. Methods. US and intraoperative liver b…

AdultMalemedicine.medical_specialtyCirrhosisSettore MED/09 - Medicina InternaArticle SubjectPopulationBariatric SurgeryPrevalence NAFLD Fibrosis Bariatric Surgery Non invasive diagnosis UltrasoundGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineFibrosisNon-alcoholic Fatty Liver DiseaseDiabetes mellitusNonalcoholic fatty liver diseasemedicinePrevalenceHumansObesityeducationNonalcoholic steatohepatitis (NASH)Retrospective StudiesUltrasonographyeducation.field_of_studyGeneral Immunology and Microbiologymedicine.diagnostic_testbusiness.industryFatty liverRRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseFibrosisSurgeryObesity Morbidultrasound (US)ROC Curve030220 oncology & carcinogenesisLiver biopsyMedicine030211 gastroenterology & hepatologyFemalebusinessResearch ArticleNonalcoholic fatty liver disease (NAFLD)BioMed Research International
researchProduct

Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response

2019

Obesity is one of the most prevalent somatic comorbidities of Major Depressive Disorder (MDD). We aimed to investigate the relationship between body mass index (BMI) and MDD, the symptomatology of the disorder as well as the outcome of antidepressant treatment.Early medication change (EMC) trial participants with BMI measurement (n = 811) were categorized according to WHO-criteria in normal or low weight (BMI  25), overweight (25- 30), and obese (≥30). Depression severity and BMI was assessed in weekly intervals up to 8 weeks. BMI at baseline and course of BMI during the study were investigated in linear regression models as possible moderators of therapy response. Possible moderators such …

AdultMalemedicine.medical_specialtyComorbidityOverweightWeight GainBody Mass IndexDepressive symptomatology03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansObesityDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryMiddle Agedmedicine.diseaseObesityAntidepressive Agents030227 psychiatryPsychiatry and Mental healthClinical PsychologyAntidepressantMajor depressive disorderFemalemedicine.symptombusinessWeight gainBody mass index030217 neurology & neurosurgeryJournal of Affective Disorders
researchProduct

Standing time and daily proportion of sedentary time are associated with pain-related disability in a one month accelerometer measurement in adults w…

2021

Abstract Objectives The association between the subjective experience of pain-related disability (PRD) and device-measured physical activity (PA) and sedentary behavior (SB) in overweight and obese adults is not well known. The aim of this study was to investigate the associations of pain markers with accelerometer-measured SB duration and different intensities of PA among physically inactive middle-aged adults with overweight or obesity. Methods This cross-sectional analysis included 72 subjects (27 men) with mean age of 57.9 (SD 6.7) years and mean BMI of 31.6 (SD 4.1) kg/m2. SB and standing time (ST), breaks in sedentary time, light physical activity (LPA) and moderate-to-vigorous physic…

AdultMalemedicine.medical_specialtyCoping (psychology)Visual analogue scalePainOverweightQuality of lifeAccelerometrymedicineBack painHumansObesitySedentary timebusiness.industryMiddle AgedOverweightmedicine.diseaseObesityOswestry Disability IndexCross-Sectional StudiesAnesthesiology and Pain MedicineQuality of LifePhysical therapyNeurology (clinical)Sedentary Behaviormedicine.symptombusinessScandinavian Journal of Pain
researchProduct

Predictors of psychological symptoms in morbidly obese patients after gastric bypass surgery

2012

Abstract Background Morbid obesity is associated with debilitating psychosocial consequences, such as depression, anxiety, and low self-esteem. One of the main goals of bariatric surgery should not only be reducing weight and counteracting co-morbid conditions, but also improving postoperative psychosocial functioning. The objective of our study was to determine the preoperative variables that could predict the psychological symptoms 6 and 12 months after surgery to improve the clinical outcome of morbidly obese patients undergoing bariatric surgery. The setting was a university hospital in Spain. Methods The study group consisted of 60 morbidly obese patients (46 women and 14 men) who had …

AdultMalemedicine.medical_specialtyCoping (psychology)media_common.quotation_subjectEmotionsGastric Bypassmedicine.disease_causeSocial supportPostoperative ComplicationsWeight lossSurveys and QuestionnairesAdaptation PsychologicalBody ImagemedicineHumansmedia_commonbusiness.industryGastric bypass surgeryMental DisordersSelf-esteemSocial Supportmedicine.diseaseSelf ConceptObesity MorbidSurgerySubstance abusePhysical therapyAnxietyFemaleSurgerymedicine.symptombusinessPsychosocialSurgery for Obesity and Related Diseases
researchProduct